Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 USD | +1.27% | -6.67% | -28.21% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | Nov. 16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | Jan. 31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Joseph Meidling
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Melissa Palmer
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-23 |
Cyrus Arman
COO | Chief Operating Officer | 43 | 22-07-08 |
Chief Tech/Sci/R&D Officer | 59 | 20-07-31 | |
Cristina de Leon
IRC | Investor Relations Contact | - | - |
Tyler Blok
LAW | General Counsel | 37 | 22-07-24 |
Seenu Srinivasan
LAW | General Counsel | - | 21-10-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
Lishomwa Ndhlovu
BRD | Director/Board Member | 54 | 21-11-23 |
Tanya Urbach
CHM | Chairman | 57 | 21-11-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 9,000 | 0 | 0 | 99.15 % |
Stock B | 0 | 6,000 | 0 | 0 | |
Stock C | 0 | 19,000 | 0 | 0 | |
Stock D | 1 | 993,809,000 | 985,393,715 ( 99.15 %) | 443,000 ( 0.0446 %) |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-28.21% | 137M | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- CYDY Stock
- Company CytoDyn Inc.